Related Experiment Video
Updated: Jan 14, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
The trio of Candida albicans, immune cells, and cancer progression: a complex interplay driving tumorigenesis
Rashi Verma1,2, Pallavi Saxena3, Luqman Ahmad Khan4
1Department of Biosciences, Jamia Millia Islamia, New Delhi, Delhi, India. rv.01.nip@gmail.com.
Abstract:
Candida albicans (C. albicans) has been identified as an opportunistic pathogen that resides as commensal in healthy population but transform into pathogen in immunocompromised individuals. Beyond secondary infection, current studies are evident it's complicated and concerning association in cancer progression. However, the interplay behind this association is still unknown. Here, we explored the trio association between the host's immune response, C. albicans and cancer progression. We acknowledged the gaps in existing knowledge, particularly the understudied mechanisms through which C. albicans promote oncogenesis and tumor progression. Key areas included chronic inflammation, influence on tumor microenvironment, immune modulation, and biofilm formation. Additionally, the review uncovered novel insights that could highlight the necessary future directions, specifically in development of therapeutics targeting this triad for better cancer management.
Related Concept Videos
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer
Cancers Originate from Somatic Mutations in a Single Cell
Psychoneuroimmunology: Diabetes and Cancer

